Since its inception, MFM has achieved significant development results. It has not only been included in multiple internationally renowned databases such as ESCI (Emerging Sources Citation Index), Scopus, Embase, etc., but also achieved its first impact factor of 1.0 in 2023, demonstrating its continuous improvement in academic quality and influence. The journal covers various aspects such as pregnancy complications, prenatal screening and diagnosis, fetal treatment, basic research, and imaging research, providing abundant academic resources for scholars in the field of maternal and fetal medicine.

In addition, MFM actively organizes high-quality domestic and international brand academic conferences, such as the China Maternal and Fetal Medicine Forum, providing valuable opportunities for scholars to exchange ideas and share research results. These efforts have not only promoted academic exchanges and cooperation in the field of maternal and fetal medicine, but also made important contributions to the development of maternal and fetal medicine in China.

自创刊以来，MFM取得了显著的发展成果。它不仅被ESCI（Emerging Sources Citation Index）、Scopus、Embase等多个国际知名数据库收录，还在2023年获得了首个影响因子1.0，显示出其学术质量和影响力的不断提升。期刊内容涵盖妊娠并发症、产前筛查与诊断、胎儿治疗、基础研究、影像学研究等多个方面，为母胎医学领域的学者提供了丰富的学术资源。

此外，MFM还积极举办高质量的国内、国际品牌学术会议，如中国母胎医学论坛等，为学者们提供了交流思想、分享研究成果的宝贵机会。这些努力不仅推动了母胎医学领域的学术交流与合作，也为中国母胎医学的发展做出了重要贡献。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映Medicine-Obstetrics and Gynecology领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。平均审稿速度为 10 Weeks ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。